Institutional Ownership
Inmed Pharmaceuticals Inc
CUSIP 457637700COM NEWINMQ1 2026
13D / 13G Filings
1
Schedule 13D/13G on record
Beneficial Filers
1
Distinct reporting persons
Largest Stake
9.9%
Max % of class reported
Institutional Holders
9
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
1 filings · latest Jan 20, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Jan 20, 2026 | Sabby Management, LLC | 13G | 9.9% | 280.1K | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Sabby Management, LLC | 220.3K | $142.0K |
| 2 | Citadel Advisors LLC | 47.0K | $30.3K |
| 3 | Two Sigma Securities, LLC | 18.7K | $12.1K |
| 4 | Ubs Group AG | 8.1K | $5.2K |
| 5 | Private Wealth Management Group, LLC | 5.0K | $3.2K |
| 6 | Sbi Securities Co., Ltd. | 300 | $193 |
| 7 | Virtu Financial LLC | 20.0K | $13 |
| 8 | Federation Des Caisses Desjardins Du Quebec | 2 | $2 |
| 9 | Banque Cantonale Vaudoise | 6 | $0 |